Page last updated: 2024-10-19

niacinamide and Disbacteriosis

niacinamide has been researched along with Disbacteriosis in 3 studies

nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.

Research Excerpts

ExcerptRelevanceReference
" This crucial role can be attributed to the gut microflora and its ability to shape human behavior and development by mediating the bioavailability of metabolites."2.66Minireview Exploring the Biological Cycle of Vitamin B3 and Its Influence on Oxidative Stress: Further Molecular and Clinical Aspects. ( Anton, E; Ciobica, A; Cojocariu, RO; Dhunna, N; Doroftei, B; Grab, D; Ilie, OD; Maftei, R; McKenna, J; Simionescu, G, 2020)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Niño-Narvión, J1
Rojo-López, MI1
Martinez-Santos, P1
Rossell, J1
Ruiz-Alcaraz, AJ1
Alonso, N1
Ramos-Molina, B1
Mauricio, D1
Julve, J1
Doroftei, B1
Ilie, OD1
Cojocariu, RO1
Ciobica, A1
Maftei, R1
Grab, D1
Anton, E1
McKenna, J1
Dhunna, N1
Simionescu, G1
Blacher, E1
Bashiardes, S1
Shapiro, H1
Rothschild, D1
Mor, U1
Dori-Bachash, M1
Kleimeyer, C1
Moresi, C1
Harnik, Y1
Zur, M1
Zabari, M1
Brik, RB1
Kviatcovsky, D1
Zmora, N1
Cohen, Y1
Bar, N1
Levi, I1
Amar, N1
Mehlman, T1
Brandis, A1
Biton, I1
Kuperman, Y1
Tsoory, M1
Alfahel, L1
Harmelin, A1
Schwartz, M1
Israelson, A1
Arike, L1
Johansson, MEV1
Hansson, GC1
Gotkine, M1
Segal, E1
Elinav, E1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Impact of the Combined Treatment of Curcumin and Resveratrol Liposomed Polyphenols With G04CB02 on the Clinical Improvement of ALS Patients[NCT04654689]Phase 290 participants (Actual)Interventional2021-11-20Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for niacinamide and Disbacteriosis

ArticleYear
NAD+ Precursors and Intestinal Inflammation: Therapeutic Insights Involving Gut Microbiota.
    Nutrients, 2023, Jun-30, Volume: 15, Issue:13

    Topics: Animals; Dysbiosis; Gastrointestinal Microbiome; Humans; Inflammation; Mammals; NAD; Niacinamide

2023
Minireview Exploring the Biological Cycle of Vitamin B3 and Its Influence on Oxidative Stress: Further Molecular and Clinical Aspects.
    Molecules (Basel, Switzerland), 2020, Jul-22, Volume: 25, Issue:15

    Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Dysbiosis; Gastrointestinal Microbiome; Humans; N

2020

Other Studies

1 other study available for niacinamide and Disbacteriosis

ArticleYear
Potential roles of gut microbiome and metabolites in modulating ALS in mice.
    Nature, 2019, Volume: 572, Issue:7770

    Topics: Akkermansia; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Disease Models, Animal;

2019